Send Inquiry

Request To Call Back

Suviray 70mg Injection

Price 24000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Units

Suviray 70mg Injection Specification

Dosage Form
pre filled syringe

Brand Name
Suviray

Salt Composition
ERENUMAB-70MG/ML

Origin of Medicine
India

Packaging Type
Vial

Pacakaging (Quantity Per Box)
1 vial per box

Indication

Life Span
See package for expiry date

Drug Type
Other

Ingredients
ERENUMAB-70MG/ML

Physical Form
Liquid

Function
Other

Recommended For
Adults and pediatric patients with suspected or confirmed COVID-19, as prescribed by a physician

Dosage
As directed by the physician; typically administered by intravenous infusion

Dosage Guidelines
To be administered under the supervision of a healthcare professional

Suitable For
Adults

Quantity
Pre filled Syringe Unit

Storage Instructions
storage between 2 C and 8 C.

Appearance
Clear to yellow liquid

Strength
70mg/vial

Marketed By
Mylan (A Viatris Company)

Batch Number
As specified on packaging

Diluent Required
Sterile Water for Injection

Preparation Required
Required to be diluted before use as per instructions

Shelf Life
24 months from manufacturing date

Contraindications
Known hypersensitivity to Remdesivir or any component of the formulation

Therapeutic Class
Antiviral Agent

Route of Administration
Intravenous (IV) infusion

Intended Use
Emergency use in hospitalized COVID-19 patients

Adverse Effects
Nausea, liver enzyme elevations, allergic reactions possible

Warning & Precautions
Not to be self-administered; monitor liver and kidney function

Prescription/Non Prescription
Prescription only

Regulatory Approval
Approved under Emergency Use Authorization (EUA)

Suviray 70mg Injection Trade Information

Minimum Order Quantity
10 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Suviray 70mg Injection

Suviray 70 mg/mL Prefilled Syringe contains Erenumab, a monoclonal antibody indicated for the preventive treatment of migraine in adults. It works by blocking the Calcitonin Gene-Related Peptide (CGRP) receptor, a key pathway involved in migraine attacks, helping reduce the frequency and severity of migraine episodes. The product is supplied as a ready-to-use prefilled syringe for subcutaneous administration and is intended for use under the supervision of a healthcare professional. It is manufactured and marketed by Novartis India Ltd. and requires refrigerated storage between 2C and 8C.

Suviray is prescribed for adults who experience recurrent migraine attacks and require preventive therapy. Clinical use has shown that CGRP receptor blockade can help decrease monthly migraine days and improve quality of life in appropriate patients.

Secure Shipping and Reliable Packaging

Shipped from reliable FOB ports in India, Suviray 70mg Injection is delivered with meticulous care via secure shipping. Each vial is encased in tamper-evident packaging to guarantee product safety and quality upon arrival. Samples may be available subject to exporter policies. For bulk orders, scheduled drop-off options ensure timely and efficient delivery. The robust packaging and temperature-controlled logistics safeguard the potency and shelf life of the product throughout transit.

FAQ's of Suviray 70mg Injection:

Frequently Asked Questions (FAQs)

Q1. What is Suviray 70 mg/mL Prefilled Syringe used for?

A: Suviray is used for the preventive treatment of migraine in adults. It helps reduce the frequency of migraine attacks and is not intended for the treatment of an acute migraine episode.

Q2. How does Suviray work?

A: Suviray contains Erenumab, which blocks the CGRP receptor. CGRP is a protein involved in triggering migraine attacks. By blocking this pathway, Suviray helps prevent migraines from occurring.

Q3. How is Suviray administered?

A: Suviray is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. Patients should receive appropriate training before self-administration.

Q4. What are the common side effects of Suviray?

A: Common side effects may include injection-site reactions (pain, redness, swelling), constipation, muscle spasms, and itching. Patients should consult their healthcare provider if symptoms persist or worsen.

Q5. How should Suviray be stored?

A: Store refrigerated between 2C and 8C in the original packaging. Do not freeze. Protect from direct light and maintain the cold chain during transportation and storage.

Q6. Can Suviray be exported internationally?

A: Yes. Suviray may be supplied internationally through licensed pharmaceutical exporters, subject to the regulatory requirements, import permits, and cold-chain logistics requirements of the destination country.

Q7. Is a prescription required?

A: Yes. Suviray is a prescription-only medicine and should be used only under the supervision of a qualified healthcare professional.

Q8. Who can benefit from Suviray treatment?

A: Adults suffering from recurrent migraine attacks who require preventive therapy may benefit from Suviray, as determined by their treating neurologist or healthcare provider.

Q9. Can patients self-administer Suviray?

A: Yes, after proper training from a healthcare professional. The injection should be administered according to the prescribing physician's instructions.

Q10. What is the primary advantage of Suviray?

A: Suviray specifically targets the CGRP receptor pathway associated with migraine development, helping reduce migraine frequency and improve long-term migraine management in eligible patients.

Tell us about your requirement